Medicare Enrolled
Dr. Nishit Choksi, M.D.
Cardiovascular Disease · Dearborn, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Choksi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choksi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Choksi
Dr. Nishit Choksi is a cardiovascular disease specialist in Dearborn, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Choksi performed 6,343 Medicare services across 3,190 unique beneficiaries.
Between the years covered by Open Payments, Dr. Choksi received a total of $49,284 from 67 pharmaceutical and/or device companies across 803 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Choksi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 2% volume in MI
$49,284 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,343
Medicare services
Top 2% in MI for cardiovascular disease
3,190
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~317 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,370 | $97 | $200 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,260 | $0 | $1 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
636 | $11 | $35 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
556 | $96 | $200 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
416 | $43 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
364 | $139 | $400 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
228 | $146 | $500 |
| Injection, dipyridamole, per 10 mg | 190 | $3 | $8 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
170 | $345 | $857 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
169 | $49 | $165 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
112 | $87 | $300 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
93 | $7 | $25 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
93 | $154 | $450 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
76 | $144 | $418 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $121 | $275 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
60 | $478 | $1,160 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
48 | $7 | $14 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
47 | $0 | $11 |
| Cardiac catheterization | 41 | $218 | $633 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
34 | $75 | $175 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
33 | $151 | $350 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $59 | $135 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
27 | $84 | $240 |
| Tube insertion in bypass graft for diagnosis A tube is inserted into a bypass graft to allow for diagnostic evaluation. A radiologist reviews the procedure. |
27 | $162 | $600 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
24 | $16 | $60 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
24 | $14 | $118 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
22 | $20 | $201 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
20 | $155 | $418 |
| Injection, fentanyl citrate, 0.1 mg | 20 | $1 | $2 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
19 | $40 | $80 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
16 | $10 | $50 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $2 | $112 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
14 | $19 | $65 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
13 | $180 | $454 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.6% high complexity
44.5% medium
51.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$49,284
Total received (2018-2024)
Avg $7,041/year across 7 years
Top 7% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
803
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,887 (48.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21,068 (42.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,328 (8.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,555
2023
$6,183
2022
$9,223
2021
$5,266
2020
$3,115
2019
$7,635
2018
$12,308
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$1,551
ShockWave Medical, Inc
$750
HEARTFLOW, INC.
$528
Endologix LLC
$378
Novartis Pharmaceuticals Corporation
$265
Kestra Medical Technology Services, Inc.
$259
Boehringer Ingelheim Pharmaceuticals, Inc.
$230
Merck Sharp & Dohme LLC
$228
Boston Scientific Corporation
$221
AstraZeneca Pharmaceuticals LP
$153
Medtronic, Inc.
$145
Inari Medical, Inc.
$144
SCPHARMACEUTICALS INC.
$91
Alnylam Pharmaceuticals Inc.
$86
Lexicon Pharmaceuticals, Inc.
$61
ABIOMED
$60
Abbott Laboratories
$50
United Therapeutics Corporation
$49
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$42
Actelion Pharmaceuticals US, Inc.
$42
Kiniksa Pharmaceuticals International, plc
$38
CORDIS US CORP.
$36
E.R. Squibb & Sons, L.L.C.
$33
Reflow Medical Inc
$32
CARDIVA MEDICAL, INC.
$30
Novo Nordisk Inc
$24
Amgen Inc.
$16
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 50.9% of 2024 payments
All-time payments by company (2018-2024) ›
Cardiovascular Systems Inc.
$11,597
Edwards Lifesciences Corporation
$5,901
Bard Peripheral Vascular, Inc.
$5,789
Philips Electronics North America Corporation
$4,312
Abbott Laboratories
$3,569
ShockWave Medical, Inc
$1,891
Boston Scientific Corporation
$1,844
Endologix LLC
$1,565
Novartis Pharmaceuticals Corporation
$1,145
Janssen Pharmaceuticals, Inc
$1,084
Endologix, Inc.
$1,037
E.R. Squibb & Sons, L.L.C.
$753
Inari Medical, Inc.
$742
AstraZeneca Pharmaceuticals LP
$695
HEARTFLOW, INC.
$528
Merck Sharp & Dohme LLC
$509
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$427
Medtronic Vascular, Inc.
$411
Amgen Inc.
$395
Medtronic, Inc.
$366
Boehringer Ingelheim Pharmaceuticals, Inc.
$359
Kestra Medical Technology Services, Inc.
$352
Astellas Pharma US Inc
$351
Actelion Pharmaceuticals US, Inc.
$320
PFIZER INC.
$302
Kiniksa Pharmaceuticals, Ltd.
$280
Impulse Dynamics (USA) Inc.
$244
Alnylam Pharmaceuticals Inc.
$179
Endologix, LLC
$159
BIOTRONIK INC.
$130
CVRx, Inc.
$123
ABIOMED
$122
HeartFlow, Inc.
$121
Merck Sharp & Dohme Corporation
$120
Lexicon Pharmaceuticals, Inc.
$116
Ablative Solutions, Inc.
$102
Shockwave Medical, Inc
$100
Bayer HealthCare Pharmaceuticals Inc.
$99
Chiesi USA, Inc.
$92
SCPHARMACEUTICALS INC.
$91
United Therapeutics Corporation
$84
SANOFI-AVENTIS U.S. LLC
$81
CORDIS US CORP.
$71
CARDIVA MEDICAL, INC.
$70
Ra Medical Systems, Inc.
$67
AngioDynamics, Inc.
$56
Penumbra, Inc.
$50
ARALEZ PHARMACEUTICALS US INC.
$47
ASAHI INTECC USA, INC.
$41
Regeneron Healthcare Solutions, Inc.
$40
Kiniksa Pharmaceuticals International, plc
$38
BOSTON SCIENTIFIC CORPORATION
$35
Reflow Medical Inc
$32
Cardinal Health 200 LLC
$31
iRhythm Technologies, Inc.
$25
Amarin Pharma Inc.
$25
Novo Nordisk Inc
$24
Cardinal Health 200, LLC
$19
Azurity Pharmaceuticals, Inc.
$19
Baxter Healthcare
$18
Terumo Medical Corporation
$14
Esperion Therapeutics, Inc.
$14
GENZYME CORPORATION
$13
IBSA Pharma Inc.
$13
Bardy Diagnostics, Inc.
$12
Lundbeck LLC
$11
Kowa Pharmaceuticals America, Inc.
$10
Top 3 companies account for 47.3% of all-time payments
Associated products mentioned in payments ›
(6571) Eagle Eye · AFX · AFX2 · AFX2 Bifurcated Endograft System · ALPHAVAC · AMPLATZER · AMPLATZER Occluders · ANGIOJET · ASAHI PTCA Guide Wire · Adempas · Alto Abdominal Stent Graft System · Arcalyst · Assure WCD · BRILINTA · Barostim Neo System · CAMZYOS · CAPELLA · CARDIVA VASCADE 6/7F VCS · CLEVIPREX · CLOSUREFAST · COREVALVE EVOLUT R · CROSSER · CT THROMBECTOMY SYSTEM KIT · CardioMEMS HF System · Carnation Ambulatory Monitor · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · DABRA laser system · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · Diamondback Coronary · Diamondback Peripheral · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · FABRY-DISEASE · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · FlowTriever · Fortify Assura · GENERAL - ATHERECTOMY · GENERAL GUIDEWIRES · HeartMate 3 Left Ventricular Assist Device · Hillrom - Cardiac Ambulatory Monitor · IGT_D Peripheral · IVUS Systems · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JETSTREAM · KENGREAL · LEQVIO · LEXISCAN · LINQ II · LUTONIX · LifeVest · Livalo · MULTAQ · MYNX CONTROL · MetaCross · Mitra Clip system · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · OPTICROSS · OPTIMIZER · OPTOWIRE · ORENITRAM · Optis Coronary Imaging System · Ovation · PERCLOSE PROGLIDE · PK Papyrus · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PRESSUREWIRE · PRO-Kinetic Energy · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · PressureWire FFR · RESONATE · Repatha · Reveal LINQ · S · SABER · SAPIEN 3 Ultra RESILIA · SEEKER · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SYMPLICITY G3 · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · Tirosint · UPTRAVI · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · Vascular Lithotripsy · Venclose Maven Catheter · Verquvo · WAINUA · WALLSTENT · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · Xact carotid stent system · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZEPHYR · ZIO XT Patch · ZONTIVITY · myLUX Patient Kit with mobile device
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (48%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for cardiovascular disease in MI.
Geographic Context
Cardiologists within 10 mi
323
Per 100K population
18.2
County median income
$59,521
Nearest hospital
BEAUMONT HOSPITAL - DEARBORN
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Choksi is a clinical cardiology specialist, with above-average Medicare volume (top 2% in MI), with mixed engagement industry engagement in the top 7% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Choksi experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Choksi performed 1,370 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choksi receive payments from pharmaceutical companies?
Yes. Dr. Choksi received a total of $49,284 from 67 companies across 803 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choksi's costs compare to other cardiologists in Dearborn?
Dr. Choksi's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choksi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Dearborn
Browse cardiologists in Dearborn ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Bard Peripheral Vascular, Inc. Payments to Doctors
See all physicians who received payments from Bard Peripheral Vascular, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology